Improved Cardiac Performance by Rosuvastatin Is Associated With Attenuations in Both Myocardial Tumor Necrosis Factor-α and p38MAP Kinase Activity in Rats After Myocardial Infarction
Improved Cardiac Performance by Rosuvastatin Is Associated With Attenuations in Both Myocardial Tumor Necrosis Factor-α and p38MAP Kinase Activity in Rats After Myocardial Infarction
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started